NCT04487041View on ClinicalTrials.gov

Tfh Dysfunction in HIV and Aging

PHASE4RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

October 30, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

December 30, 2026

Conditions
Human Influenza
Interventions
BIOLOGICAL

Standard dose influenza vaccination

Single 0.5 ml injection administered intramuscularly into participant's deltoid muscle

BIOLOGICAL

High dose influenza vaccination

4 times more concentrated single 0.7 ml injection administered intramuscularly into participant's deltoid muscle

Trial Locations (1)

33136

RECRUITING

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER